The Novavax coronavirus vaccine was 96.4% effective against the original coronavirus. It is 86.3% effective against the British strain.
–
The third phase of the NVX CoV2373 vaccine trial took place in the UK. The study covered more than 15 thousand participants aged 18 to 84 years old, 27% of them were over 65 years old.
The company also said that when it comes to severe disease, the drug has demonstrated 100% effectiveness.
– .
